Julien Dreyfus
A5017176175- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Cardiac Structural Anomalies and Repair
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Aortic Disease and Treatment Approaches
- Ultrasound in Clinical Applications
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac pacing and defibrillation studies
- Pulmonary Hypertension Research and Treatments
- Surgical Simulation and Training
- Pericarditis and Cardiac Tamponade
- Congenital Heart Disease Studies
- Venous Thromboembolism Diagnosis and Management
- Radiology practices and education
- Coronary Interventions and Diagnostics
- Cardiac and Coronary Surgery Techniques
- Simulation-Based Education in Healthcare
- Advanced X-ray and CT Imaging
- Mechanical Circulatory Support Devices
- Fuel Cells and Related Materials
- Transplantation: Methods and Outcomes
- Cardiovascular Disease and Adiposity
Centre Cardiologique du Nord
2017-2025
Institute of Cardiology
2023
Centre Hospitalier Universitaire de Rennes
2022
Hôpital Pontchaillou
2022
Centre Hospitalier Universitaire de Toulouse
2020
Hôpital Bichat-Claude-Bernard
2010-2018
Assistance Publique – Hôpitaux de Paris
2012-2018
Institut Universitaire de Cardiologie et de Pneumologie de Québec
2018
Lung Institute
2018
Centre Hospitalier Universitaire Amiens-Picardie
2018
Background— Computed tomography aortic valve calcium scoring (CT-AVC) holds promise for the assessment of patients with stenosis (AS). We sought to establish clinical utility CT-AVC in an international multicenter cohort patients. Methods and Results— Patients AS who underwent ECG-gated within 3 months echocardiography were entered into international, multicenter, observational registry. Optimal thresholds diagnosing severe determined concordant echocardiographic assessments, before being...
Abstract Aims The aim of this study was to identify determinants in-hospital and mid-term outcomes after isolated tricuspid valve surgery (ITVS) more specifically the impact regurgitation (TR) mechanism clinical presentation. Methods results Among 5661 consecutive adult patients who underwent a (TV) at 12 French tertiary centres in 2007–2017 collected from mandatory administrative database, we identified 466 (8% all surgeries) an ITVS. Most presented with advanced disease [47% New York Heart...
Isolated tricuspid valve surgery (ITVS) is considered to be a high-risk procedure, but in-hospital mortality markedly variable. This study sought develop dedicated risk score model predict the outcome of patients after ITVS for severe regurgitation (TR).
Abstract Background and aims Benefit of tricuspid regurgitation (TR) correction timing intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter conservative management according a TR clinical stage as assessed using the TRI-SCORE. Methods A total 2,413 patients with severe isolated functional were enrolled in TRIGISTRY (1217 conservatively managed, 551 valve surgery, 645 repair). The primary endpoint was at 2 years. Results TRI-SCORE low (≤3) 32%,...
Right‐sided heart failure and tricuspid regurgitation are common strongly associated with poor quality of life an increased risk hospitalizations death. While medical therapy for right‐sided is limited, treatment options include surgery and, based on recent developments, several transcatheter interventions. However, the patients who might benefit from valve interventions yet unknown, as ideal time these treatments given paucity clinical evidence. In this context, it crucial to elucidate...
Importance Correction of tricuspid regurgitation using transcatheter edge-to-edge repair (T-TEER) in addition to guideline-directed optimized medical therapy (OMT) may improve clinical outcomes. Objective To evaluate the efficacy T-TEER + OMT vs alone patients with severe, symptomatic regurgitation. Design, Setting, and Participants Investigator-initiated, prospective, randomized (1:1) trial evaluating adult The was conducted at 24 centers France Belgium (March 2021 March 2023; latest...
Data on procedural and early outcomes after transjugular transcatheter tricuspid valve replacement (TTVR) are limited.
Abstract Background and Aims Severe tricuspid regurgitation is associated with increased mortality rates, but benefit of its correction ideal timing are not clearly determined. This study aimed to identify patient subsets who might from the surgery. Methods In TRIGISTRY, an international cohort consecutive patients severe isolated functional (33 centres, 10 countries), survival rates up years were compared between underwent valve surgery (repair or replacement) those conservatively managed,...
Background— Associated tricuspid annuloplasty is recommended during left-heart valve surgery when the annulus (TA) dilated but methodology for measurement of TA size and thresholds enlargement are not clearly defined. Methods Results— Measurement diameter (TAD) was prospectively performed using 2-dimensional transthoracic echocardiography (2D-TTE) in 282 patients 4 different views (parasternal long axis, parasternal short apical 4-chamber [A4C], subcostal). TAD also measured...
Trial Registration ClinicalTrials.gov Identifier: NCT05564507
Objectives The TRI-SCORE reliably predicts in-hospital mortality after isolated tricuspid valve surgery (ITVS) on native but has not been tested in the setting of redo interventions. We aimed to evaluate predictive value for patients with ITVS and compare its accuracy conventional surgical risk scores. Methods Using a mandatory administrative database, we identified all consecutive adult who underwent at 12 French tertiary centres between 2007 2017. Baseline characteristics outcomes were...